Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 22,500 shares, an increase of 5,525.0% from the December 31st total of 400 shares. Based on an average daily volume of 85,500 shares, the days-to-cover ratio is presently 0.3 days.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on LZAGY. Redburn Atlantic upgraded Lonza Group to a “strong-buy” rating in a research note on Wednesday, November 27th. The Goldman Sachs Group raised Lonza Group to a “strong-buy” rating in a research note on Wednesday, October 9th.
Get Our Latest Analysis on LZAGY
Lonza Group Stock Performance
About Lonza Group
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Read More
- Five stocks we like better than Lonza Group
- There Are Different Types of Stock To Invest In
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is the Euro STOXX 50 Index?
- What Does the Future Hold for Eli Lilly?
- Best Aerospace Stocks Investing
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.